Kinarus Therapeutics Holding AG

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at N/A. In comparison, DPW.SW has a market cap of 42.05B. Regarding current trading prices, PRFN.SW is priced at $0.04, while DPW.SW trades at $31.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas DPW.SW's P/E ratio is 7.34. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to DPW.SW's ROE of +0.15%. Regarding short-term risk, Volatility data is not available for a full comparison. PRFN.SW has daily volatility of 12.77 and DPW.SW has daily volatility of N/A.

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at N/A. In comparison, LHA.SW has a market cap of 6.72B. Regarding current trading prices, PRFN.SW is priced at $0.04, while LHA.SW trades at $16.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas LHA.SW's P/E ratio is -8.21. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to LHA.SW's ROE of -0.02%. Regarding short-term risk, PRFN.SW is more volatile compared to LHA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PRFN.SW.

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at N/A. In comparison, FHZN.SW has a market cap of 6.52B. Regarding current trading prices, PRFN.SW is priced at $0.04, while FHZN.SW trades at $212.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas FHZN.SW's P/E ratio is 19.96. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to FHZN.SW's ROE of +0.11%. Regarding short-term risk, PRFN.SW is more volatile compared to FHZN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PRFN.SW.